A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation
Clinical trial NCT01744665 · COMPLETED
Trial details
- NCT number
- NCT01744665
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-12
- Primary completion
- 2018-09-28
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.